Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Heron Patrick J
Relationship:   Director, 10% Owner
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   33,463,806    

Indirect Shares

   27,246,926      
Direct Value   $751,390,582    

Indirect Value

   $173,686,446      
Total Shares   60,710,732      
Total Value   $925,077,028      


Anaptysbio Inc $23,220,646 Sierra Oncology Inc $446,085,534 Alpine Immune Sciences Inc $167,067,107 Aptinyx Inc. $306,248 Iterum Therapeutics Plc $10,897 Phathom Pharmaceuticals, Inc. $0 Entasis Therapeutics Holdings Inc. $2,846,897 Arcutis Biotherapeutics, Inc. $180,730 Tarsus Pharmaceuticals, Inc. $0 Frazier Lifesciences Acquisition Corp $0 Hillevax, Inc. $111,672,524 Anaptysbio Inc $23,220,646 Sierra Oncology Inc $446,085,534 Alpine Immune Sciences Inc $167,067,107 Aptinyx Inc. $306,248 Iterum Therapeutics Plc $10,897 Phathom Pharmaceuticals, Inc. $0 Entasis Therapeutics Holdings Inc. $2,846,897 Arcutis Biotherapeutics, Inc. $180,730 Tarsus Pharmaceuticals, Inc. $0 Frazier Lifesciences Acquisition Corp $0 Hillevax, Inc. $111,672,524
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    7   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    6   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   15.7%
 -59.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Trubion Pharmaceuticals, Inc TRBN 10% Owner Indirect, Di... 0 2010-10-28 0    Premium*  
            Cidara Therapeutics, Inc. CDTX Director 2015-04-20 0 2015-04-20 291,023    Premium*  
            Tobira Therapeutics Inc TBRA Director 2015-05-04 0 2015-05-04 2,668,570    Premium*  
            Collegium Pharmaceutical, Inc COLL Director, 10% Owner 2015-05-12 0 2015-05-12 1,887,332    Premium*  
            Anaptysbio Inc ANAB 10% Owner 2018-05-11 973,612 2018-05-11 973,612    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2017-02-14 8,112,121 0    Premium*  
            Alpine Immune Sciences Inc ALPN 10% Owner 2019-01-18 2,571,450 0    Premium*  
            Aptinyx Inc. APTX 10% Owner 2018-06-25 3,190,079 2018-06-25 0    Premium*  
            Iterum Therapeutics Plc ITRM Director 2020-07-01 9,006 2020-07-01 1,538,316    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM Director 2019-07-22 0 2023-11-09 3,728,875    Premium*  
            Phathom Pharmaceuticals, Inc. PHAT 10% Owner 2020-06-12 5,827,415 2020-06-12 31,446    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2020-01-09 1,299,953 2020-01-09 0    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT Director, 10% Owner 2024-06-14 18,826 2024-03-04 8,808,979    Premium*  
            Passage Bio, Inc. PASG Director, 10% Owner 2020-03-03 0 2020-03-03 5,009,219    Premium*  
            Vaxcyte, Inc. PCVX Director 2020-06-16 0 2020-06-16 2,309,554    Premium*  
            Tarsus Pharmaceuticals, Inc. TARS 10% Owner 2020-10-20 1,917,157 2020-10-20 0    Premium*  
            Frazier Lifesciences Acquisition... FLAC Director 2020-12-11 1,000,000 2020-12-11 0    Premium*  
            Hillevax, Inc. HLVX Director, 10% Owner 2024-04-04 8,544,187 2022-05-03 0    Premium*  
* Premium Members only  

Records found :    57         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HLVX Hillevax, Inc. Director   –       •       •   2022-05-03 4 B $17.00 $30,000,002 D/D 1,764,706 8,535,337 3.92 %
HLVX Hillevax, Inc. Director   –       •       •   2024-04-04 4 B $14.50 $128,325 D/D 8,850 8,544,187 3.92 %
ARQT Arcutis Biotherapeutics, ... Director   –       •       •   2022-08-05 4 B $20.00 $5,000,000 D/D 250,000 8,684,232 3.92 %
ARQT Arcutis Biotherapeutics, ... Director   –       •       •   2023-10-24 4 B $2.50 $200,000 D/D 80,000 8,764,232 3.92 %
ARQT Arcutis Biotherapeutics, ...   –       •      –    2024-03-04 4 B $9.50 $199,994 I/I 21,052 8,785,284 0.01 %
ARQT Arcutis Biotherapeutics, ... Director   –       •       •   2020-02-04 4 A $0.00 $0 I/I 9,533,758 10,042,790 0 -
ARQT Arcutis Biotherapeutics, ... Director   –       •       •   2020-02-04 4 B $17.00 $8,500,000 I/I 500,000 10,542,790 2.25 %
  57  Records found
  1   2   3     
  Page 3 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us